| 名稱(chēng) | AI-Edigene® FGFR3(E17)-TACC3(E10) Fusion |
| 型號(hào) | CBP20200R |
| 報(bào)價(jià) |  |
| 特點(diǎn) | AI-Edigene® FGFR3(E17)-TACC3(E10) Fusion |
產(chǎn)品搜索
產(chǎn)品分類(lèi)
相關(guān)文章
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話(huà)：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話(huà)：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測(cè)標(biāo)準(zhǔn)品 > Fusion > CBP20200RAI-Edigene® FGFR3(E17)-TACC3(E10) Fusion
- 詳細(xì)內(nèi)容
CBP20200R | |
| Format | RNA |
| Description | FGFR3-TACC3 results from the fusion of FGFR3 and TACC3, demonstrating constitutive kinase activity, transforming activity in culture and ability to drive tumor growth in xenografts (PMID: 25294908, PMID: 22837387). FGFR3-TACC3 has been identified in lung adenocarcinoma and glioblastoma (PMID: 25294908, PMID: 22837387). |
| Technical Data | |
| Left Gene | FGFR3 |
| Left Breakpoint | chr4:1808661:+ |
| Right Gene | TACC3 |
| Right Breakpoint | chr4:1739325:+ |
| Cosmic ID | COSF1434 |
| Buffer | RNase-free H2O |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purity | Download for COA |
| RNA electrophoresis | Download for COA |
| Sanger sequencing |
|
| Storage | -80℃ |
| Expiry | 12 months from the date of manufacture |
會(huì)員_a.png)